Antisense Treatment in Human Prostate Cancer and Melanoma

E-ISSN： 1873-5576|10|6|555-565

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.6, 2010-09, pp. : 555-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cabazitaxel for the treatment of prostate cancer

By Michielsen Dirk PJ Braeckman Johan G Denis Louis

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 977-982

Informa Healthcare

Access to resources Recommend Favorite

Hormonal treatment for prostate cancer

By Harris K.A. Small E.J.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 3, 2001-03 ,pp. : 493-510

Informa Healthcare

Access to resources Recommend Favorite

Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 209-221

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting angiogenesis for the treatment of prostate cancer

By Antonarakis Emmanuel S Carducci Michael A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

An evaluation of bicalutamide in the treatment of prostate cancer

By Schellhammer Paul F

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1313-1328

Informa Healthcare

Access to resources Recommend Favorite